Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression †
Titel:
Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression †
Auteur:
Obermannová, R. Van Cutsem, E. Yoshino, T. Bodoky, G. Prausová, J. Garcia-Carbonero, R. Ciuleanu, T. Garcia Alfonso, P. Portnoy, D. Cohn, A. Yamazaki, K. Clingan, P. Lonardi, S. Kim, T.W. Yang, L. Nasroulah, F. Tabernero, J.